Wroclaw University of Health and Sport Sciences
Wroclaw, Dolnyśląsk, 51-612, Poland
NCT Number: NCT07310329
This randomized, single-blind, placebo-controlled pilot study investigated the effects of high-dose vitamin D₃ supplementation and football-specific physical exercise on vitamin D metabolite concentrations in professional male football players. The study aimed to evaluate the acute response of circulating vitamin D metabolites, including 25-(OH)D₃, 24,25-(OH)₂D₃, and 3-epi-25-(OH)D₃, following a single oral dose of 500,000 IU cholecalciferol combined with high-intensity intermittent exercise typical of competitive football.
Twenty professional football players from a Polish top-division club participated in the study. Participants were randomly assigned to either the supplementation group (SGP) receiving 500,000 IU of vitamin D₃ or the placebo group (PGP) receiving an identical volume of placebo oil. The intervention was administered 48 hours prior to an intra-squad game. Blood samples were collected at three time points: baseline (T3), pre-match (T4), and post-match (T5). The primary outcome was the change in serum 25-(OH)D₃ concentration. Secondary outcomes included changes in 24,25-(OH)₂D₃ and 3-epi-25-(OH)D₃ levels, as well as their ratios. The study also assessed whether physical exercise modulates vitamin D metabolism.
The findings demonstrated that high-dose vitamin D₃ supplementation significantly increased serum 25-(OH)D₃ (↑198%) and 3-epi-25-(OH)D₃ (↑444%) levels, while football-specific exercise itself induced moderate increases in vitamin D metabolites. The results suggest that skeletal muscle may play a key role in vitamin D storage and release in response to exercise. The supplementation was well tolerated, with no adverse events observed.
Looking for future studies?
Notify Me18 year–35 year
Male
Interventional
Not applicable
Wroclaw, Dolnyśląsk, 51-612, Poland
This pilot study was designed to explore the combined effects of high-dose vitamin D₃ supplementation and acute physical exercise on vitamin D metabolism in professional football players. The study responds to growing scientific interest in understanding how vitamin D status influences performance, recovery, and muscle function in athletes. While most previous studies have focused on chronic, low-to-moderate supplementation, this trial examined the response to a single, pharmacological dose of cholecalciferol in a controlled experimental setting.
Study Design
The study employed a randomized, single-blind, placebo-controlled, parallel-group design. Participants were randomly assigned to one of two groups:
Supplementation Group (SGP) - received a single oral dose of 500,000 IU vitamin D₃ (Vigantol Oil, P&G Health, Germany);
Placebo Group (PGP) - received an identical amount of placebo (vegetable oil).
The supplementation was administered 48 hours before a standardized intra-squad football match (ISG), conducted under conditions simulating a competitive game. All players followed the same training schedule and diet during the study.
Participants
A total of 20 professional male football players (aged 18-35) from a Polish top-league club volunteered to participate. Inclusion criteria included active professional status, regular training participation, and no use of vitamin D or calcium supplements in the previous 3 months. Exclusion criteria included musculoskeletal injuries, metabolic disorders, or refusal to sign informed consent.
Measurements
Blood samples were collected at three time points:
T3: baseline (before supplementation),
T4: 48 hours post-supplementation (pre-match),
T5: immediately after the intra-squad game.
Serum concentrations of 25-(OH)D₃, 24,25-(OH)₂D₃, and 3-epi-25-(OH)D₃ were determined using LC-MS/MS. Additional biochemical variables (hemoglobin, glucose, testosterone, cortisol, ferritin, calcium, CK) were analyzed to monitor physiological status.
Outcomes
Primary Outcome: Changes in serum 25-(OH)D₃ concentrations after supplementation and exercise.
Secondary Outcomes: Changes in 24,25-(OH)₂D₃ and 3-epi-25-(OH)D₃ levels, metabolite ratios.
Ethics
The study was approved by the Ethics Committee of the Wroclaw University of Health and Sport Sciences (Resolution No. 1/2024, March 1, 2024). All participants signed written informed consent.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A single oral dose of 500,000 IU vitamin D₃ (Vigantol Oil, P&G Health, Germany) was administered 48 hours before the intra-squad football match to assess its acute effects on vitamin D metabolite concentrations.
A single oral dose of vegetable oil matching the vitamin D₃ solution in color and consistency was administered 48 hours before the intra-squad football match.
Time frame: Baseline (before supplementation), 48 hours after supplementation, and immediately after the football match (2 days after supplementation).
Serum concentrations of 25(OH)D₃ will be measured using isotope-dilution liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS). The primary outcome assesses the effect of a single high-dose vitamin D₃ supplementation combined with physical exercise on 25(OH)D₃ concentration in professional football players.
Time frame: Baseline (T3), 48 hours post-supplementation (T4), and post-exercise (T5)
To evaluate the effect of vitamin D₃ supplementation and physical exercise on 24,25(OH)₂D₃ levels using ID-LC-MS/MS.
Time frame: Baseline (before supplementation), 48 hours after supplementation, and immediately after the football match (2 days after supplementation).
To assess changes in the ratios between major vitamin D metabolites as indicators of metabolic transformation rate and vitamin D turnover in response to supplementation and physical activity.
Wroclaw University of Health and Sport Sciences
Other
Effects of High-Dose Vitamin D Supplementation and Physical Exercise on Vitamin D Metabolites in Professional Football Players: A Pilot Study
Acronym: VitD-Football
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01827345
Avitaminosis, Deficiency Diseases
Gainesville, Florida, United States
View Trial DetailsNCT07718594
Behavior, Cycling and Treadmill Exercise
Taipei, Taipei City, Taiwan
View Trial DetailsNCT07697027
Athletes, Male
Guangzhou, Guangdong, China
View Trial DetailsNCT06017180
Athletes, Volleyball
Manisa, Turkey (Türkiye)
View Trial Details